Stay updated on Pembrolizumab in Lymphoma Subtypes Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphoma Subtypes Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page shows a new revision label (v3.6.4), indicating a minor update to the page's documentation/system version.
    Difference
    0.0%
    Check dated 2026-07-25T17:58:43.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The Revision field was updated from v3.6.2 to v3.6.3, signaling a minor page update. This change does not modify the visible content or functionality of the page.
    Difference
    0.0%
    Check dated 2026-07-04T13:15:55.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.2, signaling a backend update to the ClinicalTrials.gov record. This change does not appear to alter study text or visible content.
    Difference
    0.0%
    Check dated 2026-06-27T05:55:01.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added recruitment status indicating the study is no longer enrolling. Also added new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated header formatting with a new revision tag (Revision: v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-13T00:23:16.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This change reflects versioning metadata rather than content changes.
    Difference
    0.0%
    Check dated 2026-06-05T22:52:58.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added to the page, replacing the previous Revision: v3.5.3. This reflects a new version of the page content without altering the study details.
    Difference
    0.0%
    Check dated 2026-05-15T14:28:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphoma Subtypes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.